IPSEN US Oncology - Revenue Tracker 2015

Ok we will post monthly actual revenue sales results here monthly throughout 2015.

 

Ipsen anticipates filing a Supplemental New Drug Application seeking an indication for Somatuline® in NETs in the first half of 2014. Maximum incremental annual cost associated with the launch of Somatuline® in the NET indication in the US is expected to range from 30 million euros to 40 million euros. As a result, US breakeven2, initially expected in 2014, is postponed to 2017. Ipsen will continue to implement cost containment initiatives to minimize impact on overall Group profitability.

Ok so will start you off as a -40 million

And the break even pressure. OMG.

OK LETS keep this revenue tracker updated.

 

January 2015. Week 1

We are in the Red big time

 

You call that a launch gift?

Can I hear anymore bullshit here.

 

Well the food sucks so we got some money back I hope on this menu

 

We will never make it

 

Ok so we are -140 million to start here.

Isn't funny how when a foreign investment comes in they really get a bunch of US former BIG PHARMA bunch to suck yo and kiss ass to say what everyone wants to hear all the time.

I mean it is like has been talking heads repeating to each other what the French want to hear them say.

And no comp plan. Now this sounds like the Ipsen we all love so much.

 

Let's add the departure tracker to this thread.

People will be continue to interview and BE LEAVING

 

I am so glad I didn't take a job with this confused company....................the interview rooms were fully stocked with food and drink and they flew me to CA, so that was nice............

 

You're a complete douche! Low rent, no class shithead

 

I haven't spoken with one person who feels this way...not one!

 

Sell something and go buy a nice gift for someone else...you make me I'll!

 

Go speak to a customer

REVENUE is not where it needs to be!!

LETS GO

Now make sure you follow Rules of Engagement

Everyone is watching

 

Yea who will be the first to fall into ROE trap.

 

Any big consortium contracts signed? Any sales stocking updates. How are the current forecasts looking?

We will check back

 

WEEK 2

Revenue stocking not showing any more activity. According to my check on major wholesalers the big 3 not much movement either

Lofty forcast will strangle this launch

 

Disagree jack off... Very doable in my mind

 

What's great about all these threads the way they written. Genius

When anyone searches Ipsen in Google this what comes up.

So let's keep the future misery going

Oh and I will bet $1000 that Ipsen missed its forcast by 30% or greater in 2015

 

Man it is COLD outside!!!

 

I am out here and I must admit this is going to be a long haul. It is not like this indication is a major activity and all I am hearing is that Novartis drug is s cover all for many indications so why one off us